‘A necessary step’

First PBAC recommendation for Covid vaccine addition to NIP The Pharmaceutical Benefits Advisory Committee (PBAC) has recommended that the Covid-19 vaccine, Comirnaty, be listed on the National Immunisation Program (NIP) in its December meeting. It is the first PBAC recommendation for a Covid-19 vaccine, which the committee noted is “a necessary step” to enable transition